The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help. The interviews webpage also uses YouTube, where subtitles and translations are generated automatically by AI; please be advised to exercise caution when precise interpretation is required. For further support with YouTube, visit YouTube Help.
What are the signs and symptoms of AML, and which may get overlooked?
Charles Craddock
March 16, 2026
For AML World Awareness Day 2026, Know AML was pleased to speak with Know AML ambassadors Erik Aerts, a specialist hematology nurse based in Switzerland, and Charles Craddock, an acute myeloid leukemia (AML) physician based in the United Kingdom. We asked, What are the signs and symptoms of AML, and which may get overlooked?
Erik explains that common symptoms of AML include ongoing tiredness and weakness, bleeding, infections (sometimes with fever), shortness of breath, and dizziness. He notes that if a patient has a combination of fatigue, bruising, and infection, this indicates to him that they may need to be tested for AML.
Charles agrees that some patients with AML may develop symptoms gradually, such as ongoing fatigue, repeated infections, or bleeding. In these cases, doctors may carry out tests to better understand the specific type of AML and choose the most appropriate treatment. He also highlights that sometimes patients with AML can become unwell very quickly, with symptoms such as heavy bleeding, severe infections, or kidney problems. In these cases, patients may require urgent hospital admission and immediate treatment.
Thank you to our official financial supporter, Thermo Fisher Scientific. All content is developed independently by SES in collaboration with an expert ambassador group; supporters are allowed no influence on our resources.
